Literature DB >> 15481085

Anthracotic index and DNA methylation status of sputum contents can be used for identifying the population at risk of lung carcinoma.

Sato Konno1, Yukio Morishita, Masakatsu Fukasawa, Yujian Shu, Daye Wang, Ryota Tanaka, Yuko Minami, Tatsuo Iijima, Masayuki Noguchi.   

Abstract

BACKGROUND: Sputum cytology for the mass screening of lung carcinoma is a noninvasive, repeatable, and useful examination, but the detection rate is usually < 0.05% and the reliability is not high.
METHODS: The anthracotic index (AI) and methylation status of the promoter regions of the p16, adenomatous polyposis coli (APC), and retinoic acid receptor-beta (RARbeta) genes were examined in 356 sputum specimens after routine cytologic examination.
RESULTS: The mean AI of specimens from males was significantly higher than that from females. AI increased with increasing age and smoking index. The mean AI of patients with lung carcinoma was significantly higher than that of the nonaffected population. Furthermore, the mean AI of the specimens with or without cancer cells from patients with cancer was significantly higher than that of the nonaffected population. Abnormal methylation of the p16, APC, and RARbeta genes was detected in 21.7%, 28.2%, and 26.9% of specimens from patients with cancer, respectively. These ratios were significantly higher than those of the nonaffected populations (0%, 3.9%, and 7.6%, respectively). The incidences of abnormal methylation of the three genes were not associated with histologic classification, smoking index, gender, age, or occupation.
CONCLUSIONS: These findings suggested that the AI and abnormal methylation status were useful for identifying a population at risk of lung carcinoma using mass screening of cytology specimens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481085     DOI: 10.1002/cncr.20643

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.

Authors:  Bo Zhang; Wei Zhu; Ping Yang; Tao Liu; Mei Jiang; Zhi-Ni He; Shi-Xin Zhang; Wei-Qing Chen; Wen Chen
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

2.  Oxidative stress, telomere shortening, and DNA methylation in relation to low-to-moderate occupational exposure to welding fumes.

Authors:  Huiqi Li; Maria Hedmer; Tomasz Wojdacz; Mohammad Bakhtiar Hossain; Christian H Lindh; Håkan Tinnerberg; Maria Albin; Karin Broberg
Journal:  Environ Mol Mutagen       Date:  2015-05-27       Impact factor: 3.216

Review 3.  The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis.

Authors:  Di Liu; Hongli Peng; Qi Sun; Zhongyao Zhao; Xinwei Yu; Siqi Ge; Hao Wang; Honghong Fang; Qing Gao; Jiaonan Liu; Lijuan Wu; Manshu Song; Youxin Wang
Journal:  Int J Environ Res Public Health       Date:  2017-06-23       Impact factor: 3.390

Review 4.  Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer.

Authors:  Keigo Yokoi; Keishi Yamashita; Masahiko Watanabe
Journal:  Int J Mol Sci       Date:  2017-03-30       Impact factor: 5.923

5.  Multi-Gene Expression in Anthracosis of the Lungs as One of the Risk Factors for Non-Small Cell Lung Cancer

Authors:  Hamidreza Jamaati; Naghmeh Bahrami; Payam Tabarsi; Adnan Khosravi; Arda Kiani; Atefeh Abedini; Rahim Ahmadi; Somayeh Sharifynia; Abdolreza Mohamadnia
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

6.  P16INK4a gene promoter methylation as a biomarker for the diagnosis of non-small cell lung cancer: An updated meta-analysis.

Authors:  Lei Tuo; Sha Sha; Zhang Huayu; Ke Du
Journal:  Thorac Cancer       Date:  2018-06-21       Impact factor: 3.500

Review 7.  Molecular sputum analysis for the diagnosis of lung cancer.

Authors:  A J Hubers; C F M Prinsen; G Sozzi; B I Witte; E Thunnissen
Journal:  Br J Cancer       Date:  2013-07-18       Impact factor: 7.640

8.  Gene methylation biomarkers in sputum as a classifier for lung cancer risk.

Authors:  Shuguang Leng; Guodong Wu; Donna M Klinge; Cynthia L Thomas; Elia Casas; Maria A Picchi; Christine A Stidley; Sandra J Lee; Seena Aisner; Jill M Siegfried; Suresh Ramalingam; Fadlo R Khuri; Daniel D Karp; Steven A Belinsky
Journal:  Oncotarget       Date:  2017-07-15

Review 9.  Non-blood circulating tumor DNA detection in cancer.

Authors:  Muyun Peng; Chen Chen; Alicia Hulbert; Malcolm V Brock; Fenglei Yu
Journal:  Oncotarget       Date:  2017-08-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.